Using non-fasting cholesterol tests to predict heart events
Part of Heart & circulation clinical trials.
This study looks at whether cholesterol levels measured without fasting can help predict future heart and blood vessel events in people living in the community. If you join, your non-fasting blood test results may be tracked to see how well they forecast cardiovascular risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old
- Sign an informed consent form (agree to take part)
- Plan to be able to stay involved for the next year (life expectancy > 1 year)
- Have no mental health condition that could interfere with taking part
- Be willing to participate and follow the study plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well questionnaires and cholesterol test results match a person’s future heart risk. It may help researchers improve how doctors spot who is at higher risk and who can benefit from prevention.
This study tests whether quickly increasing cholesterol-lowering medication can reduce the risk of another heart attack or stroke. It is for people who have heart disease from blocked arteries.
This trial tests a new way to check heart risk and start treatment for cholesterol in people coming to the emergency room with chest pain or possible heart attack. It aims to see if early risk assessment and treatment can prevent future heart problems.
This study looks for new body markers (including possible genetic traits) to better predict who is likely to have future cardiovascular events. Your results could help doctors estimate risk and choose prevention strategies more accurately.
This is a research study testing whether specific gene changes are linked to fatty liver and a cholesterol pattern that raises heart risk. It may help researchers understand who is most likely to develop these conditions and why, which could guide future prevention.
This study looks at blood markers (“biomarkers”) to better understand health risk in older adults who have multiple long-term illnesses and are taking statin medicines. It may help researchers predict outcomes and improve care for people with complex health needs.
Hear when a new Lipid trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.